Mumbai, Jan 28: Pharma major Glenmark Pharmaceuticals Inc USA (Glenmark) has received the final approval by the United States Food and Drug Administration for Metronidazole Vaginal Gel 0.75%, the generic version of MetroGel-Vaginal Gel 0.75%, of Bausch Health US, LLC.
According to IQVIATM sales data for a 12-month period ending in November 2021, the MetroGelVaginal Gel 0.75% market achieved annual sales of approximately $60.4 million.
(UNI)
Follow our WhatsApp channel